🔎 Trials Near Me

Akèy › Psoryaz › Massachusetts

Etid klinik pou Psoryaz nan Massachusetts

9 etid pou Psoryaz ap chèche patisipan nan sit nan Massachusetts.

Vil nan Massachusetts

Tèks ofisyèl etid la (Anglè)

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

  • Kuchnir Dermatology & Dermatologic Surgery, Milford
Ap rekriteFaz 3
Laj 12 a 17 · Tout sèks · Mizajou Sep 3, 2026 · NCT06979453

The CorEvitas Psoriasis (PSO) Registry

  • Waltham
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT02707341

PPD™ CorEvitas™ Psoriasis (PSO) Rapid Response Non-Interventional Study

  • CorEvitas, LLC, Waltham
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT07615712

CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry

  • CorEvitas, LLC, Waltham
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06100991

PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study

  • CorEvitas, LLC, Waltham
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT07648602

Multi-Center PAMPA Study

  • Brigham and Women's Hospital, Boston
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Mar 30, 2026 · NCT05004727

A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis

  • Local Institution, Waltham
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 23, 2024 · NCT05744466

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.